Overview
Dr. Dante J. Pieramici graduated with honors from the Johns Hopkins University School of Medicine and completed Ophthalmology Residency at the Wilmer Eye Institute. He receive vitreoretinal fellowship training at the Emory Eye Center in Atlanta Georgia. Dr. Pieramici has held full-time academic positions at the Yale University Eye Center and the Wilmer Eye Institute, where he served as the Assistant Chief of Service and Director of Ocular Trauma. Currently he is the Codirector of the California Retina Research Foundation, a partner of the California Retina Consultants, and Assistant Clinical Professor of Ophthalmology at the Doheny Eye Center in Southern California. Dr. Pieramici has published over 100 articles, 16 book chapters, and has edited 3 books on retinal diseases. He lectures nationally and internationally on retinal diseases and ocular trauma.Dr. Pieramici’s research interests have been varied, and include clinical and basic science projects aimed at better understanding of the underlying pathophysiology of ocular diseases, so as to improve treatments for patients with age-related macular degeneration, diabetic retinopathy, retinal vascular diseases, and severe ocular injuries. He has been a clinical investigator, principal investigator, or reading center investigator in numerous NIH and pharmaceutical company sponsored clinical trials. Dr Pieramici has helped in the development of new surgical techniques including limited macular translocation and 25-gauge (small incision) vitrectomy surgery. Currently he is involved in the development of new drug delivery techniques for various retinal vascular diseases.Dr. Pieramici has received the Achievement Award from the American Academy of Ophthalmology and Honor Award from the American Society of Retinal Specialists. He is a member of the American Academy of Ophthalmology, the Retina Society, the Macula Society, the American Society of Retinal Specialists, the Association for Research in Vision and Ophthalmology, the American Society of Ocular Trauma where he serves as Vice President, and the Pan-American Ophthalmologic Society amongst others. Dr Pieramici is a member of S.E.E International and regularly trains international ophthalmologists from undeserved areas.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients.
Dr. Pieramici is rated as an Advanced provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Macular Edema (DME), Diabetic Retinopathy, and Vitrectomy.
His clinical research consists of co-authoring 54 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER MEDICARE
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1801 N Solar Dr, Ste 145, Oxnard, CA 93030
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Homayoun Tabandeh is an Ophthalmologist in Encino, California. Dr. Tabandeh is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Retinal Detachment, Diabetic Retinopathy, and Vitrectomy. Dr. Tabandeh is currently accepting new patients.
California Retina Consultants
Dr. Castellarin graduated first in his class from the University of Verona School of Medicine in Verona, Italy. Following his ophthalmology training, he completed an ophthalmology residency summa cum laude and then became an instructor of ophthalmology at the Verona School of Medicine. In addition to working in a clinical practice, Dr. Castellarin was a primary investigator in the Verona Diabetes Study.After several years of research and teaching in Italy, Dr. Castellarin moved to the United States where he completed a general surgery internship at St. Barnabas Medical Center. Then, during an additional ophthalmology residency at the University of Medicine and Dentistry in Newark , New Jersey, Dr. Castellarin was chosen to be chief resident. He was also presented with the Alfonse Cinotti Award in recognition of his academic and professional excellence as an ophthalmology resident. Dr. Castellarin received his vitreoretinal fellowship training at Emory University with pioneer surgeon, Dr. Thomas Aaberg.Dr. Castellarin has recently been nationally recognized as the top retina fellow. He was presented with the prestigious Ronald M. Michels Fellowship Award for his contributions to vitreoretinal research and surgery. He was also honored with a National Eye Institute Travel Grant during his work at Emory University. His research interests include diabetic retinopathy, age-related macular degeneration and retinal pigment epithelium transplantation. Dr. Castellarin has also been involved in several national multicenter clinical trials and results of his work have been published in highly acclaimed journals such as Ophthalmology, Retina, the American Journal of Ophthalmology, the British Journal of Ophthalmology and The Lancet. Dr. Castellarin is a diplomate of the American Board of Ophthalmology, a member of the Association for Research in Vision and Ophthalmology and the American Academy of Ophthalmology.As vitreoretinal specialists, we provide comprehensive medical and surgical treatment for all disorders of the retina, macula and vitreous. We focus on the diagnosis, prevention and treatment of these conditions. Many abnormalities of the retina and vitreous may cause visual loss. These disorders include macular degeneration, diabetic retinopathy, retinal detachment, macular holes, macular edema and epiretinal membranes. Our practice has multiple locations throughout Central California to serve our patients. Dr. Castellarin is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Retinal Vein Occlusion, and Vitrectomy.
Steven Schwartz is an Ophthalmologist in Beverly Hills, California. Dr. Schwartz is rated as a Distinguished provider by MediFind in the treatment of Retinal Artery Occlusion. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Vein Occlusion, and Retinal Artery Occlusion.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Age-Related Macular Degeneration (ARMD)
- Diabetic Macular Edema (DME)Dr. Pieramici isElite. Learn about Diabetic Macular Edema (DME).
- Late-Onset Retinal DegenerationDr. Pieramici isElite. Learn about Late-Onset Retinal Degeneration.
- Distinguished
- Diabetic RetinopathyDr. Pieramici isDistinguished. Learn about Diabetic Retinopathy.
- Geographic AtrophyDr. Pieramici isDistinguished. Learn about Geographic Atrophy.
- Retinal DetachmentDr. Pieramici isDistinguished. Learn about Retinal Detachment.
- Retinal Vein OcclusionDr. Pieramici isDistinguished. Learn about Retinal Vein Occlusion.
- Advanced
- Central Serous ChorioretinopathyDr. Pieramici isAdvanced. Learn about Central Serous Chorioretinopathy.
- Choroid Plexus CarcinomaDr. Pieramici isAdvanced. Learn about Choroid Plexus Carcinoma.
- Cone DystrophyDr. Pieramici isAdvanced. Learn about Cone Dystrophy.
- Cone Rod Dystrophy Amelogenesis Imperfecta
- Cone-Rod DystrophyDr. Pieramici isAdvanced. Learn about Cone-Rod Dystrophy.
- Doyne Honeycomb Retinal DystrophyDr. Pieramici isAdvanced. Learn about Doyne Honeycomb Retinal Dystrophy.
- Experienced
- Adult-Onset Vitelliform Macular Dystrophy (AVMD)
- Bietti Crystalline Dystrophy (BCD)Dr. Pieramici isExperienced. Learn about Bietti Crystalline Dystrophy (BCD).
- CataractDr. Pieramici isExperienced. Learn about Cataract.
- Coats DiseaseDr. Pieramici isExperienced. Learn about Coats Disease.
- Familial Exudative VitreoretinopathyDr. Pieramici isExperienced. Learn about Familial Exudative Vitreoretinopathy.
- GlaucomaDr. Pieramici isExperienced. Learn about Glaucoma.